Literature DB >> 26273296

Elastography Evaluation of Benign Thyroid Nodules in Patients Affected by Hashimoto's Thyroiditis.

Carlo Cappelli1, Ilenia Pirola1, Elena Gandossi1, Annamaria Formenti1, Barbara Agosti1, Maurizio Castellano1.   

Abstract

The aim of the present prospective study was to evaluate the predictive value of elastography in benign thyroid nodules of patients affected by Hashimoto's thyroiditis (HT). From January 2011 to January 2012, 242 nodules in patients affected by HT were submitted to fine needle aspiration cytology (FNAC). All of the patients underwent sonography and elastography performed before FNAC. 230 (95%) nodules were benign, 8 papillary cancers, and 4 follicular lesions. Score 1 was found in 79.1% of benign lesions (sensitivity 79.1%; specificity 66.7%; PPV 97.8%; NPV 14.3%; accuracy 78.5%; p < 0.05). In order to evaluate the outcome of thyroid ultrasound echogenicity in relation to elastography features of nodule(s), all the patients with benign nodules were stratified according to their hypoechoic pattern of thyroid (mild-moderate and severe). Following stratification score 1 was found in 84.2% of benign nodules (sensitivity 75.0%; specificity 88.9%; PPV 27.3%; NPV 98.4%; accuracy 88.2%; p < 0.0001) of patients with a mild-moderate ultrasound thyroid hypoechogenicity, whereas it was found in 60% of benign nodules (p = 0.715) of patients with a marked thyroid hypoechogenicity. Elastography appears to have limited value in detecting thyroid cancer in patients affected by Hashimoto's thyroiditis with severe hypoechoic thyroid tissue.

Entities:  

Year:  2015        PMID: 26273296      PMCID: PMC4530237          DOI: 10.1155/2015/367054

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


1. Introduction

Hashimoto's thyroiditis (HT), also known as chronic lymphocytic thyroiditis, is an autoimmune disease characterized by lymphocytic infiltration of the gland and production of autoantibodies that target thyroid peroxidase and/or thyroglobulin, resulting in tissue destruction and progressive loss of thyroid function [1]. After ultrasound (US) introduction into clinical practice in the late 1960s, thyroid ultrasonography proved to be very effective in the diagnostic approach to thyroid disorders [2-4]. Many studies have investigated whether the ultrasonographic characteristics of thyroid nodules are useful indicators of histological malignancy. Overall, these investigations suggest a few ultrasonographic features that are significantly more frequent in malignant than in benign thyroid nodules, and some have tried to define a set of characteristics that identify nodules at higher risk of malignancy [5]. The characteristic US pattern of Hashimoto's glands consists of an array of tiny hypoechoic nodules that may become confluent, interspersed with echogenic fibrous bands [6]; nevertheless, US should be interpreted with caution due to the diffuse heterogeneity and the presence of pseudonodules related to ongoing inflammation. Elastography is a method which assesses the risk of the malignancy and provides information about the degree of hardness in tissue. Recently elastography has been proposed as a new technique for differentiating pseudonodules from nodules in HT [7] and benign from malignant lesions of thyroid gland [5, 8–10]. HT is able to change the hardness of the thyroid tissue. There have been few studies that have shown using elastography that HT is able to change the hardness of the thyroid gland decreasing its capacity to distinguish benign from malignant nodule [11, 12]. The aim of the present prospective study was to evaluate the predictive value of elastography in the characterization of benign thyroid nodules of patients affected by HT.

2. Materials and Methods

From January 2011 to January 2012, 250 consecutive patients affected by HT with at least one solid nodule were submitted to fine needle aspiration cytology (FNAC). Cases were selected from patients referred to our thyroid unit for US-guided FNAC. The selection criteria were as follows: (1) indication to FNAC in accordance with the major guidelines [5, 14]; (2) positive test for thyroglobulin antibody (TgAb) and/or thyroid peroxidase antibody (TPOAb) and a thyroid gland with hypoechoic pattern at US evaluation. All of the patients underwent sonography and elastography performed by the same skilled sonographer (CC) before US-guided FNAC. Thyroid sonography and elastography were performed with a real-time instrument (Vision 900; Hitachi Medical System, Tokyo, Japan) equipped with a linear probe with a central frequency of 6–13 MHz. The sonographic hypoechogenicity of thyroid gland (Figures 1(a) and 1(b)) was classified from mild-moderate to severe in accordance with literature [15-18].
Figure 1

(a) Hashimoto's thyroiditis with mild sonographic hypoechogenicity. (b) Hashimoto's thyroiditis with severe sonographic hypoechogenicity.

Findings at elastography were classified according to the elasticity scores by Rago et al. [13]. Briefly, score 1 indicated nodules with high elasticity, score 2 nodules with intermediate elasticity, and score 3 nodules with low elasticity (Table 1). To minimize the intraobserver variability, the freehand compression applied on the neck was standardized by real-time measurement displayed on a numeric scale (graded 1–5) to maintain an intermediated level optimal for elastographic evaluation [6, 8].
Table 1

The applied standard elastography color scoring system according to Rago criteria [13]. A score of 1 indicates even elasticity in the whole nodule, score 2 elasticity only at the peripheral part of the nodule, and score 3 no elasticity in the nodule and in the posterior shadowing.

Score
Elasticity in the whole nodule

Intermediate elasticity in the nodule

Low elasticity in the nodule
The serum concentrations of TgAb (normal range: <60 U/mL) and TPOAb (normal range: <60 U/mL) were measured using immunochemiluminescent assays employing commercial kits (Brahms, Hennigsdorf, Germany). All patients gave their informed consent to participate in the study, which was performed in accordance with the Declaration of Helsinki. All data were analyzed with SPSS version 17 software (SPSS Inc., Chicago, IL). Comparisons between groups were performed by an analysis of variance general linear model; a χ 2 test was used for categorical variables. Statistical significance was considered at p < 0.05.

3. Results

Two hundred fifty consecutive patients (202 female, 48 male), mean age 52.2 ± 11.2 years, were submitted to US-guided FNAC. Of the 262 nodules submitted to cytology, 20 (7.6%) appeared to be nondiagnostic, and as a consequence 16 patients were excluded from the study. Among 234 patients two hundred forty-two nodules were collected: 230 (95%) were benign, 8 papillary cancers, and 4 follicular lesions. Histology confirmed 8 papillary and 4 follicular cancers. The lesions classified as scores 1, 2, and 3 on elastography are listed in Table 2.
Table 2

Elasticity score of the 242 nodules submitted to cytology that resulted in benign nodules or carcinoma.

Elasticity scoreBenign (n)Cancer (n)Tot. (n)
Score 11822184
Score 239544
Score 39514
Score 1 was found in 182/230 (79.1%) of benign lesions (sensitivity 79.1%; specificity 66.7%; positive predictive value 97.8%; negative predictive value 14.3%; accuracy 78.5%; p < 0.05). All 227 patients with benign nodules were stratified in accordance with the echogenic pattern of thyroid gland (mild-moderate/severe): 128 (56%) patients presented a mild-moderate thyroid echogenicity (Group A) and 99 (44%) a severe one (Group B). The two groups were then stratified in accordance with the elastographic scoring of the nodule (scores 1, 2, and 3). The two groups were superimposable for gender (86/42 versus 64/35 F/M), age (53.1 ± 12.8 versus 49.6 ± 10, years), and TSH values (3.9 ± 1.1 versus 4.0 ± 0.9 mU/L). Following stratification, a significant different behavior emerged in the two groups (Figure 2). In detail, score 1 was found in 84.2% of benign nodules of patients with a mild-moderate ultrasound thyroid hypoechogenicity (sensitivity 75.0%; specificity 88.9%; positive predictive value 27.3%; negative predictive value 98.4%; accuracy 88.2%; p < 0.0001) and in 60% of patients with a marked thyroid hypoechogenicity (sensitivity 50.0%; specificity 62.8%; positive predictive value 5.9%; negative predictive value 96.2%; accuracy 62.2%; p = 0.715).
Figure 2

Elasticity score in nodules with benign diagnostic cytology in relation to thyroid hypoechogenicity pattern.

4. Discussion

As described by Gutekunst et al. thirty years ago HT is associated with a diffuse reduction in thyroid echo levels (hypoechogenicity) [19], with a correlation between serum TPOAb levels and the degree of hypoechogenicity [18, 20], that have been classified from mild-moderate to severe [17, 18]. After US introduction into clinical practice in the late nineteen sixties thyroid ultrasonography proved to be very effective in the diagnostic approach to thyroid disease [21]. Elastography has been proposed as a new and promising technique for thyroid nodules evaluation [8–10, 13]. The first evidence suggested that interobserver agreement is not reliable in the diagnosis of malignant lesions but recent data clearly shows a good interobserver and intraobserver reproducibility in detecting thyroid cancer [22, 23]. Magri et al. evidenced that shear wave elastography correctly defined the elasticity of thyroid nodules independently of the coexistence of autoimmune thyroiditis, being able to differentiate nodular tissue from the surrounding parenchyma [6]. The results of the present study confirm that elastography is effective in distinguishing between benign and malignant nodules in patients affected by HT, showing however a lack of accuracy in patients affected by HT presenting diffuse marked hypoechoic thyroid echo-structure (i.e., severe sonographic thyroid hypoechogenicity). On the contrary, two recent studies have shown that strain index reflects malignancy better than the elastoscore in HT patients [11, 12]. Taking into account the elastography performance in our patients without stratification by sonographic hypoechogenicity, our results also showed a lack of accuracy, but for the first time, we showed that elastography has a high performance when the thyroid echogenicity is not severe. As already reported by Pedersen et al. [24] stronger inflammatory process has been shown in severe sonographic thyroid hypoechogenicity due to the diffuse infiltration of the thyroid parenchyma with lymphocytes and fibrosis [20, 25]. It is conceivable that a benign process, likely represented by nodular fibrosis, is responsible for the hard elastographic pattern of many thyroid nodules in patients with HT. In fact, histologically proven fibrotic nodules of the thyroid appear to be characterized by a high stiffness index at elastographic evaluation [26] and several hard nodules were detected in patients previously submitted to radioiodine treatment which is known to induce fibrosis [27]. Taking into account these studies, we have hypothesized that higher inflammatory process, lymphocytic infiltration, and fibrosis characterize HT with severe sonographic thyroid hypoechogenicity, but these reactions are also present in benign nodule(s) therefore reducing the accuracy of elastographic evaluation in these patients. Our results are in accordance with those of Scacchi et al. obtained in acromegalic patients, who showed that higher fibrosis developed in acromegalic thyroid patients justifying the worst performance of elastography in detecting cancer [28]. The present study has few limitations; firstly no histological data of benign nodules are given and secondly there is the relative small size of patients enrolled in the study. Another potential confounding factor may be the possibility that “benign nodules” were represented by pseudonodular fibrotic infiltration. Unfortunately, we do not have histological data about cytologically proven benign nodule(s). Only a small number of patients (n = 26) with large benign nodules were submitted to thyroidectomy and in all these patients histology confirmed the benign nature of the lesions (data not shown). However, we must underline the accuracy in terms of sensitivity, specificity, and false negative and positive rate of FNAC [29, 30] to consider this procedure the gold-standard in differentiating benign from malignant thyroid nodules in many guidelines [5, 14]. Moreover, not only cytology [29, 30] but also elastography [13, 26] well distinguishes true nodules from pseudonodular ones. For these reasons we believe that the lack of histological data in our study cannot diminish the value of our results. Prospective large studies are needed to confirm our observation. In conclusion our study has demonstrated a high prevalence of hard thyroid nodule at elastography evaluation in patients with HT. Interestingly this is particularly evident when the hypoechoic pattern of thyroid gland is severe, suggesting an extensive infiltration of the thyroid parenchyma with lymphocytes and fibrosis. The hypothesis that nodular fibrosis might account for this elastography pattern is conceivable but needs histopathological confirmation. Elastography evidences a lack of accuracy when it is performed in patients affected by HT presenting diffuse severe hypoechoic thyroid echo-structure.
  30 in total

1.  Nodule or pseudonodule? Differentiation in Hashimoto's thyroiditis with sonoelastography.

Authors:  D Yildirim; B Gurses; B Gurpinar; B Ekci; B Colakoglu; A Kaur
Journal:  J Int Med Res       Date:  2011       Impact factor: 1.671

2.  High diagnostic accuracy and interobserver reliability of real-time elastography in the evaluation of thyroid nodules.

Authors:  Federico Ragazzoni; Maurilio Deandrea; Alberto Mormile; M Josefina Ramunni; Francesca Garino; Gabriella Magliona; Manuela Motta; Bruno Torchio; Roberto Garberoglio; Paolo Limone
Journal:  Ultrasound Med Biol       Date:  2012-04-27       Impact factor: 2.998

3.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.

Authors:  Hossein Gharib; Enrico Papini; Ralf Paschke; Daniel S Duick; Roberto Valcavi; Laszlo Hegedüs; Paolo Vitti
Journal:  Endocr Pract       Date:  2010 May-Jun       Impact factor: 3.443

Review 4.  Chronic autoimmune thyroiditis.

Authors:  C M Dayan; G H Daniels
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

5.  Acoustic radiation force impulse elastography for differentiation of benign and malignant thyroid nodules with concurrent Hashimoto's thyroiditis.

Authors:  Bo-Ji Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu; Dan-Dan Li; Xiao-Wan Bo; Xiao-Long Li; Le-Hang Guo; Xiao-Hong Xu; Shen Qu
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

6.  Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis.

Authors:  Flavia Magri; Spyridon Chytiris; Valentina Capelli; Sarah Alessi; Elisa Nalon; Mario Rotondi; Sara Cassibba; Fabrizio Calliada; Luca Chiovato
Journal:  Clin Endocrinol (Oxf)       Date:  2012-01       Impact factor: 3.478

7.  Interobserver agreement and intraobserver reproducibility in thyroid ultrasound elastography.

Authors:  Dong-Jun Lim; Si Luo; Min-Hee Kim; Sun-Hee Ko; Yongmin Kim
Journal:  AJR Am J Roentgenol       Date:  2012-04       Impact factor: 3.959

8.  Micronodulation: ultrasonographic sign of Hashimoto thyroiditis.

Authors:  H C Yeh; W Futterweit; P Gilbert
Journal:  J Ultrasound Med       Date:  1996-12       Impact factor: 2.153

9.  Differentiation of benign from malignant thyroid lesions: calculation of the strain ratio on thyroid sonoelastography.

Authors:  Ping Xing; Linfeng Wu; Chunmei Zhang; Shu Li; Chunbo Liu; Changjun Wu
Journal:  J Ultrasound Med       Date:  2011-05       Impact factor: 2.153

10.  Elastography in the differential diagnosis of thyroid nodules in Hashimoto thyroiditis.

Authors:  Mustafa Şahin; Erman Çakal; Mustafa Özbek; Aşkin Güngünes; Müyesser Sayki Arslan; Esra Tutal Akkaymak; Bekir Uçan; Ilknur Öztürk Ünsal; Nujen Çolak Bozkurt; Tuncay Delibaşi
Journal:  Med Oncol       Date:  2014-07-03       Impact factor: 3.064

View more
  1 in total

Review 1.  Nodular Thyroid Disease in the Era of Precision Medicine.

Authors:  Dario Tumino; Giorgio Grani; Marta Di Stefano; Maria Di Mauro; Maria Scutari; Teresa Rago; Laura Fugazzola; Maria Grazia Castagna; Fabio Maino
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-23       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.